Indication
Pituitary-dependent Cushing's disease
Pituitary-dependent Cushing's disease is an endocrine disorder classified as a form of endogenous ACTH-dependent hypercortisolism, primarily arising from a benign adrenocorticotropic hormone (ACTH)–secreting pituitary neuroendocrine tumor (corticotroph adenoma). Read more about Pituitary-dependent Cushing's disease
2 drugs 2 manufacturers
Drugs that treat it
Common Pituitary-dependent Cushing's disease therapies.
RECORLEV (levoketoconazole)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPituitary-dependent Cushing's disease is an endocrine disorder classified as a form of endogenous ACTH-dependent hypercortisolism, primarily arising from a benign adrenocorticotropic hormone (ACTH)–secreting pituitary neuroendocrine tumor (corticotroph adenoma).
This sustained hypersecretion of ACTH drives bilateral adrenal cortical hyperplasia and unchecked systemic cortisol overproduction, disrupting the hypothalamic-pituitary-adrenal axis.
The condition impacts multiple body systems, predominantly affecting adults and leading to clinical hallmarks such as central obesity, facial plethora, purple abdominal striae, proximal muscle weakness, hypertension, and glucose intolerance.
Affected individuals also face substantial risks of long-term metabolic, cardiovascular, skeletal, and neuropsychiatric complications stemming from chronic hypercortisolemia.
- nih.gov
Pituitary-dependent Cushing's disease is an endocrine disorder classified as a form of endogenous ACTH-dependent hypercortisolism, primarily arising from a benign adrenocorticotropic hormone (ACTH)–secreting pituitary neuroendocrine tumor (corticotroph adenoma)
- nih.gov
Pituitary-dependent Cushing's disease is an endocrine disorder classified as a form of endogenous ACTH-dependent hypercortisolism, primarily arising from a benign adrenocorticotropic hormone (ACTH)–secreting pituitary neuroendocrine tumor (corticotroph adenoma) The condition impacts multiple body systems, predominantly affecting adults and leading to clinical hallmarks such as central obesity, facial plethora, purple abdominal striae, proximal muscle weakness, hypertension, and glucose intoleran...
- nih.gov
This sustained hypersecretion of ACTH drives bilateral adrenal cortical hyperplasia and unchecked systemic cortisol overproduction, disrupting the hypothalamic-pituitary-adrenal axis The condition impacts multiple body systems, predominantly affecting adults and leading to clinical hallmarks such as central obesity, facial plethora, purple abdominal striae, proximal muscle weakness, hypertension, and glucose intolerance
- nih.gov
This sustained hypersecretion of ACTH drives bilateral adrenal cortical hyperplasia and unchecked systemic cortisol overproduction, disrupting the hypothalamic-pituitary-adrenal axis
- endocrine.org
The condition impacts multiple body systems, predominantly affecting adults and leading to clinical hallmarks such as central obesity, facial plethora, purple abdominal striae, proximal muscle weakness, hypertension, and glucose intolerance Affected individuals also face substantial risks of long-term metabolic, cardiovascular, skeletal, and neuropsychiatric complications stemming from chronic hypercortisolemia
- nih.gov
Affected individuals also face substantial risks of long-term metabolic, cardiovascular, skeletal, and neuropsychiatric complications stemming from chronic hypercortisolemia
Personalize your experience
Follow Pituitary-dependent Cushing's disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.